Quantitation of benzo[a]pyrene-DNA adducts by postlabeling with 14C-acetic anhydride and accelerator mass spectrometry

Chemico-Biological Interactions

Volumn 126, Issue 3, 2000, Pages 171-183

  Goldman, Radoslav ^a   Day, Billy W ^b   Carver, Tonya A ^c   Mauthe, Robert J ^d   Turteltaub, Kenneth W ^c   Shields, Peter G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^d PFIZER INC   (United States)

Author keywords

14C postlabeling; Benzo a pyrene; Carcinogenesis; DNA adduct; Molecular epidemiology

Indexed keywords

ACETIC ANHYDRIDE; BENZO[A]PYRENE; CARBON 14; BENZO(A)PYRENE DNA ADDUCT; BENZO(A)PYRENE-DNA ADDUCT; CARBON; CARCINOGEN;

ACETYLATION; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MASS SPECTROMETRY; METHODOLOGY; NONHUMAN; QUANTITATIVE ASSAY; ANIMAL; ATOMIC ABSORPTION SPECTROMETRY; CATTLE; CHEMISTRY;

ACETIC ANHYDRIDES; ACETYLATION; ANIMALS; BENZO(A)PYRENE; CARBON RADIOISOTOPES; CARCINOGENS, ENVIRONMENTAL; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA ADDUCTS; ISOTOPE LABELING; MASS SPECTROMETRY; SPECTROPHOTOMETRY, ATOMIC;

EID: 0034195193     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(00)00160-5     Document Type: Article

References (34)

1. Bartsch H., Hietanen E. The role of individual susceptibility in cancer burden related to environmental exposure. Environ.Health Perspect. 104(Suppl. 3):1996;569-577.
2. Dipple A. DNA adducts of chemical carcinogens. Carcinogenesis. 16:1995;437-441.
3. Harris C.C. Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis. 10:1989;1563-1566.
4. Harris C.C. Chemical and physical carcinogenesis: advances and perspectives. Cancer Res. 51:1991;5023s-5044.
5. Perera F.P. Environment and cancer: who are susceptible? Science. 278:1997;1068-1073.
6. Yuspa S.H., Shields P.G. Etiology of cancer: chemical. DeVita V.T., Hellman S., Rosenberg S.A. Cancer: Principles and Practice of Oncology. 1997;185-202 Lippincott-Raven, Philadelphia.
7. Groopman J.D., Wogan G.N., Roebuck B.D., Kensler T.W. Molecular biomarkers for aflatoxins and their application to human cancer prevention. Cancer Res. 54:1994;1907s-1911s.
8. Wogan G.N. Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research. Environ. Health Perspect. 98:1992;167-178.
9. C.P. Wild, P. Pisani, Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology, IARC Sci. Publ. (1997) 143-158.
10. Warren A.J., Shields P.G. Molecular epidemiology: carcinogen-DNA adducts and genetic susceptibility. Proc. Soc. Exp. Biol. Med. 216:1997;172-180.
11. Poirier M.C. DNA adducts as exposure biomarkers and indicators of cancer risk. Environ. Health Perspect. 105(Suppl. 4):1997;907-912.
12. Phillips D.H., Hewer A., Martin C.N., Garner R.C., King M.M. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature. 336:1988;790-792.
13. Poirier M.C., Weston A. Human DNA adduct measurements: state of the art. Environ. Health Perspect. 104(Suppl. 4):1996;883-893.
14. Hemminki K., Autrup H., Haugen A. DNA and protein adducts. Toxicology. 101:1995;41-53.
15. Strickland P.T., Routledge M.N., Dipple A. Methodologies for measuring carcinogen adducts in humans. Cancer Epidemiol. Biomarkers Prev. 2:1993;607-619.
16. 32P-postlabeling assay for polycyclic aromatic hydrocarbon-DNA adducts. Mutagenesis. 8:1993;121-126.
17. Shields P.G., Bowman E.D., Harrington A.M., Doan V.T., Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 53:1993;3486-3492.
18. Vogel J.S., Turteltaub K.W., Finkel R., Nelson D.E. Accelerator mass spectrometry. Anal. Chem. 67:1995;353A-359A.
19. MacGregor J.T., Farr S., Tucker J.D., Heddle J.A., Tice R.R., Turteltaub K.W. New molecular endpoints and methods for routine toxicity testing. Fundam. Appl. Toxicol. 26:1995;156-173.
20. Cheng S.C., Hilton B.D., Roman J.M., Dipple A. DNA adducts from carcinogenic and noncarcinogenic enantiomers of benzo[a]pyrene dihydrodiol epoxide. Chem. Res. Toxicol. 2:1989;334-340.
21. Pei G.K., Moschel R.C. Aralkylation of 2′-deoxyguanosine: medium effects on sites of reaction with 7-(bromomethyl)benz[a]anthracene. Chem. Res. Toxicol. 3:1990;292-295.
22. Davis J.C., Proctor I.D., Southon J.R., Caffee M.W., Heikkinen D.W., Roberts B., Moore T.L., Turteltaub K.W., Nelson D.E., Loyd D.H., Vogel J.S. LLNL/UC AMS Facility and Research Program. Nuclear Inst. Method Phys. Res. B52:1990;269-272.
23. 14C data. Radiocarbon. 19:1977;355-363.
24. Vogel J.S. Rapid production of graphite without contamination for biomedical AMS. Radiocarbon. 34:1992;344-350.
25. Wachowiak R., Connors K.A. N-Methylimidzaole-catalyzed acetylation of hydroxy compounds prior to gas chromatographic separation and determination. Anal. Chem. 51:1979;27-30.
26. Ambrosone C.B., Freudenheim J.L., Graham S., Marshall J.R., Vena J.E., Brasure J.R., Michalek A.M., Laughlin R., Nemoto T., Gillenwater K.A., Harrington A.M., Shields P.G. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. J. Am. Med. Assoc. 276:1996;1494-1501.
27. Kelsey K.T., Hankinson S.E., Colditz G.A., Springer K., Garcia-Closas M., Spiegelman D., Manson J.E., Garland M., Stampfer M.J., Willett W.C., Speizer F.E., Hunter D.J. Glutathione-S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases. Cancer Epidemiol. Biomarkers Prev. 6:1997;511-515.
28. Thompson P.A., Shields P.G., Freudenheim J.L., Stone A., Marshall J.R., Graham S., Vena J.E., Laughlin R., Nemoto T., Kadlubar F.F., Ambrosone C.B. Genetic polymorphisms in catechol-O-methyltransferase (COMT), menopausal status and breast cancer risk. Cancer Res. 58:1998;2107-2110.
29. Kinzler K.W., Vogelstein B. Gatekeepers and caretakers. Nature. 386:1997;761-763.
30. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Ogreid D., Ulvik A., Vu P., Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289.
31. Vineis P., Bartsch H., Caporaso N., Harrington A.M., Kadlubar F.F., Landi M.T., Malaveille C., Shields P.G., Skipper P., Talaska G. et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature. 369:1994;154-156.
32. Badawi A.F., Hirvonen A., Bell D.A., Lang N.P., Kadlubar F.F. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res. 55:1995;5230-5237.
33. Li D., Wang M., Dhingra K., Hittelman W.N. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res. 56:1996;287-293.
34. Wu X., Shi H., Jiang H., Kemp B., Hong W.K., Delclos G.L., Spitz M.R. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis. 18:1997;967-973.